Photoactivatable Surface-Functionalized Diatom Microalgae for Colorectal Cancer Targeted Delivery and Enhanced

Joachim Delasoie1, Philippe Schiel1, Sandra Vojnovic2

  • 1Department of Chemistry, Fribourg University, Chemin du Musée 9, 1700 Fribourg, Switzerland.

Pharmaceutics
|May 30, 2020
PubMed

Insights

Researchers developed a novel drug delivery system using microalgae to target cancer cells. This bio-inspired approach enhances chemotherapy effectiveness and reduces side effects through targeted drug release and light activation.

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Cancer Therapy

Background:

  • Conventional chemotherapy faces challenges with systemic toxicity and severe side effects.
  • Targeted drug delivery systems are crucial for enhancing cancer treatment efficacy and minimizing damage to healthy tissues.

Purpose of the Study:

  • To design, synthesize, and characterize a bio-inspired hybrid multifunctional drug delivery system using diatom microalgae.
  • To evaluate the system's ability to target colorectal cancer (CRC) cells and achieve controlled drug release.
  • To investigate the enhancement of cytotoxic efficacy through photoactivation.

Main Methods:

  • Functionalization of diatom microalgae surface with vitamin B12-photoactivatable molecules.
  • Loading of rhenium(I) tricarbonyl anticancer complexes onto the functionalized microalgae.
  • Assessment of cellular adherence to CRC cells and drug release kinetics.
  • Evaluation of cytotoxic efficacy with and without light irradiation.

Main Results:

  • The hybrid system demonstrated enhanced adherence to colorectal cancer cells.
  • A slow and controlled release of chemotherapeutic drugs was observed.
  • Photoactivation of the microalgae surface significantly enhanced the overall toxicity and cytotoxic efficacy of the anticancer drugs, with up to a 2-fold increase.

Conclusions:

  • The developed diatom microalgae-based system represents a promising targeted drug delivery strategy for cancer therapy.
  • Spatial-temporal light activation combined with targeted delivery can lead to lower effective drug concentrations, reducing patient side effects and burden.